IL25 and hepatocellular carcinoma: IL-25 has been found to activate M2 TAMs, induce the expression of chemokine CXCL10, and promote epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma (HCC), thereby facilitating tumor progression and metastasis (69).